| Disease | cytomegalic inclusion disease |
| Comorbidity | C1145670|respiratory failure |
| Sentences | 1 |
| PubMedID- 25705409 | The patient then rapidly developed irreversible type ii respiratory failure despite the administration of etanercept and an anti-cytomegalovirus agent and died on the eighth re-mv day. |
Page: 1